By ΠΠ»Π»Π°Ρ Π±Π°Π΄ΠΈΡ Π.Π.
ΠΠ»Π»Π°Ρ Π±Π°Π΄ΠΈΡ Π.Π., 2019
ΠΠ°Π½Π½ΠΎΠ΅ ΡΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ, ΠΏΠΎΠ΄Π³ΠΎΡΠΎΠ²Π»Π΅Π½Π½ΠΎΠ΅ Π²Π΅Π΄ΡΡΠΈΠΌΠΈ ΡΠ΅ΠΏΡΠΎΠ΄ΡΠΊΡΠΎΠ»ΠΎΠ³Π°ΠΌΠΈ, ΠΎΡΠ²Π΅ΡΠ°Π΅Ρ ΡΠ΅ΠΎΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ Π΅ΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΠΈ ΠΊΠΎΠ½ΡΡΠΎΠ»ΠΈΡΡΠ΅ΠΌΠΎΠΉ ΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ ΡΠΈΡΠ½ΠΈΠΊΠΎΠ², Π²ΠΊΠ»ΡΡΠ°Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠ΅ ΡΡ Π΅ΠΌΡ ΠΈ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ. ΠΠ²ΡΠΎΡΡ, ΡΡΠ΅Π΄ΠΈ ΠΊΠΎΡΠΎΡΡΡ ΠΏΠΈΠΎΠ½Π΅ΡΡ ΠΠΠ, ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°ΡΡ Π²Π°ΠΆΠ½ΠΎΡΡΡ ΠΌΠΎΠ½ΠΈΡΠΎΡΠΈΠ½Π³Π° ΡΠΎΠ»Π»ΠΈΠΊΡΠ»ΠΎΠ³Π΅Π½Π΅Π·Π° ΠΈ ΠΎΡΠ΅Π½ΠΊΠΈ ΠΎΠ²Π°ΡΠΈΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ΅Π·Π΅ΡΠ²Π°, ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ Ρ Π½ΠΈΠ·ΠΊΠΈΠΌ ΠΎΡΠ²Π΅ΡΠΎΠΌ ΠΈΠ»ΠΈ Π²ΡΡΠΎΠΊΠΈΠΌ ΡΠΈΡΠΊΠΎΠΌ. ΠΡΠΎΠ±ΠΎΠ΅ Π²Π½ΠΈΠΌΠ°Π½ΠΈΠ΅ ΡΠ΄Π΅Π»ΡΠ΅ΡΡΡ ΠΏΠ΅ΡΠ΅ΡΠΌΠΎΡΡΡ ΡΡΠ°Π½Π΄Π°ΡΡΠ½ΡΡ ΠΏΡΠΎΡΠΎΠΊΠΎΠ»ΠΎΠ² Π΄Π»Ρ ΠΏΡΠΎΡΠΈΠ»Π°ΠΊΡΠΈΠΊΠΈ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΠΉ, ΡΠ°ΠΊΠΈΡ ΠΊΠ°ΠΊ ΡΠΈΠ½Π΄ΡΠΎΠΌ Π³ΠΈΠΏΠ΅ΡΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ ΡΠΈΡΠ½ΠΈΠΊΠΎΠ² ΠΈ ΠΌΠ½ΠΎΠ³ΠΎΠΏΠ»ΠΎΠ΄Π½Π°Ρ Π±Π΅ΡΠ΅ΠΌΠ΅Π½Π½ΠΎΡΡΡ. Π Π°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°ΡΡΡΡ ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π° ΠΌΠΈΠ½ΠΈΠΌΠ°Π»ΡΠ½ΠΎΠΉ ΡΡΠΈΠΌΡΠ»ΡΡΠΈΠΈ ΠΈ ΠΠΠ Π² Π΅ΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΌ ΡΠΈΠΊΠ»Π΅ Ρ ΡΠΎΡΠΊΠΈ Π·ΡΠ΅Π½ΠΈΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ, Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΠΈ ΠΈ ΡΠ΅Π½ΡΠ°Π±Π΅Π»ΡΠ½ΠΎΡΡΠΈ, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ Π² ΡΠΎΡΠ΅ΡΠ°Π½ΠΈΠΈ Ρ ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠΎΠΌ ΠΊΡΠΈΠΎΠΊΠΎΠ½ΡΠ΅ΡΠ²ΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΡΠΌΠ±ΡΠΈΠΎΠ½ΠΎΠ². ΠΠΏΠΈΡΠ°Π½Ρ ΠΏΠΎΡΠ»Π΅Π΄Π½ΠΈΠ΅ Π΄ΠΎΡΡΠΈΠΆΠ΅Π½ΠΈΡ, Π²ΠΊΠ»ΡΡΠ°Ρ Π½ΠΎΠ²ΡΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΡ ΠΈ Π°Π²ΡΠΎΠΌΠ°ΡΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Π½ΡΠ΅ ΡΠΈΡΡΠ΅ΠΌΡ Π£ΠΠ-Π°Π½Π°Π»ΠΈΠ·Π°.
Allahbadiya G.N., 2019
This guide, prepared by world-renowned reproductive specialists, covers essential theoretical and practical issues in natural and controlled ovarian stimulation, detailing various schemes and agents. Contributors, some of whom were pioneers in IVF, highlight the significance of monitoring folliculogenesis and assessing ovarian reserve, particularly in "poor responders" and high-risk patients. It emphasizes the need to revise standard stimulation protocols to prevent adverse side effects and complications like ovarian hyperstimulation syndrome and multiple pregnancies. The benefits of minimal stimulation and natural cycle IVF are justified based on clinical efficacy, safety, and cost-effectiveness, especially when combined with frozen embryo transfers. Recent advancements, such as highly active long-acting corifollitropin alfa and automated ultrasound follicle volume calculation systems (SonoAVC), are also presented.